EYE2O Trademark

Trademark Overview

On Monday, August 22, 2022, a trademark application was filed for EYE2O with the United States Patent and Trademark Office. The USPTO has given the EYE2O trademark a serial number of 97558711. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2025. This trademark is owned by Samil Pharmaceutical Co., Ltd. The EYE2O trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of ophthalmic conditions; eye drops; artificial tears

General Information

Serial Number97558711
Word MarkEYE2O
Filing DateMonday, August 22, 2022
Status700 - REGISTERED
Status DateTuesday, January 7, 2025
Registration Number7637388
Registration DateTuesday, January 7, 2025
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements

Description of MarkThe mark consists of the word "EYE" followed by a subscript "2" and a capital "O".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of ophthalmic conditions; eye drops; artificial tears
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSamil Pharmaceutical Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeoul 06666
KR
Party NameSamil Pharmaceutical Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 06666
KR
Party NameSamil Pharmaceutical Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 06666
KR

Trademark Events

Event DateEvent Description
Friday, June 16, 2023SUSPENSION LETTER WRITTEN
Monday, September 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 21, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, November 4, 2022ASSIGNED TO LIE
Friday, November 4, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, June 8, 2023ASSIGNED TO EXAMINER
Friday, June 16, 2023LETTER OF SUSPENSION E-MAILED
Friday, June 16, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 17, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, March 7, 2024SUSPENSION INQUIRY WRITTEN
Thursday, March 7, 2024INQUIRY TO SUSPENSION E-MAILED
Thursday, March 7, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 15, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024SUSPENSION LETTER WRITTEN
Friday, April 26, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, November 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, November 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 7, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, April 26, 2024LETTER OF SUSPENSION E-MAILED

Related Keywords

pharmaceutical treatment ophthalmic preparations artificial tears drops conditions diseases prevention